Seaford Pharmaceuticals – Seaford Pharmaceuticals

Tag: Seaford Pharmaceuticals

Seaford Pharmaceuticals Inc: Pioneering Excellence in Healthcare and Pharmaceuticals – GHP Awards 2023

In the ever-evolving world of healthcare and pharmaceuticals, it’s crucial to recognize organizations that go above and beyond to make a meaningful impact on the industry. Seaford Pharmaceuticals Inc is proud to share our journey from nomination to triumph at the Global Health & Pharma (GHP) Healthcare and Pharmaceutical Awards 2023. We are delighted to have been honored with two prestigious awards: “Healthcare Marketing Specialists of the Year 2023 – Canada” and “Innovation Award in R&D Excellence 2023 – Canada.”

Strengthens Partnership with Persōn & Covey, Inc.

In January 2023, our CEO Ron Seales and President Tamara Seales embarked on an extraordinary journey to the heart of California. Their destination: Persōn & Covey, Inc., an illustrious pillar in the health and personal care industry with a rich heritage dating back to 1941.
The ethos of Persōn & Covey, Inc. has always been deeply rooted in collaborative innovation with the medical community.

Seaford Pharmaceuticals Receives CSHP Certificate of Recognition

Seaford Pharmaceuticals is delighted to announce its receipt of the esteemed “Certificate of Recognition” from the Canadian Society of Hospital Pharmacists (CSHP). This recognition underscores Seaford Pharmaceuticals’ unwavering commitment to patient care and its dedication to advancing safe and effective medication use in hospitals and other collaborative healthcare settings across Canada.

Seaford Pharmaceuticals Hosts Distinguished Delegation from Diagnostic Green

Seaford Pharmaceuticals was honored to host a distinguished delegation from Diagnostic Green, a leading provider of trusted high-quality fluorescence products for physicians worldwide. The delegation included Richard Manner (President and Managing Director), Mike Broome (VP Sales & Business Development), and Michael Manner (Marketing Specialist).

At Seaford Pharmaceuticals, we are proud to reflect on a significant achievement that took place on December 14, 2019. This marked a milestone in our journey as we partnered with the Glen Vincent Health Centre under the impactful Adopt-A-Clinic Program. The Glen Vincent Health Centre, nestled at Trevennion Park Road, St Andrew, and classified as a Type III clinic, holds a special place within the community. Serving as the only pediatric health center within the South East Regional Health Authority (SERHA), its role in providing essential healthcare services is invaluable. In the presence of our esteemed President, Tamara Seales, and under the leadership of our CEO, Ron Seales, we committed to providing crucial funds for the acquisition of clinical equipment, essential office supplies, and the execution of minor infrastructure repairs and maintenance. This commitment was driven by our shared vision to bolster the operational capacity of the health center, ensuring uninterrupted access to high-quality medical care for those it serves.

Seaford Pharmaceuticals’ Ongoing Support for Glen Vincent Health Centre Through Adopt-A-Clinic Program

At Seaford Pharmaceuticals, we are proud to be part of an ongoing initiative that began on December 14, 2019, when we partnered with the Glen Vincent Health Centre under the impactful Adopt-A-Clinic Program. The Glen Vincent Health Centre, nestled at Trevennion Park Road, St Andrew, and classified as a Type III clinic, holds a special place within the community.

Another Award For Seaford Pharmaceuticals!

Seaford Pharmaceuticals Receives Small Business of the Year Award from the Mississauga Board of Trade We are delighted to announce that Seaford Pharmaceuticals Inc. has been honored with the prestigious Small Business of the Year Award by the Mississauga Board of Trade (MBOT). This remarkable achievement is a testament to our unwavering dedication, innovative practices, … Continue reading “Another Award For Seaford Pharmaceuticals!”

Seaford Pharmaceuticals Inc. is recognized as one of the Top 10 Therapeutics Companies In Canada by Life Sciences Review!

SEAFORD PHARMACEUTICALS Transforming Pharmaceutical Marketing in Canada The world needs more pharmaceutical companies to expand into international markets for better access to life-saving drugs. However, with the complex regulatory frameworks set by governments, obtaining market authorization for prescription drugs can be a challenge. Seaford Pharmaceutical understands this and has complemented its extensive knowledge of … Continue reading “Seaford Pharmaceuticals Inc. is recognized as one of the Top 10 Therapeutics Companies In Canada by Life Sciences Review!”

It’s Official, Seaford Pharmaceuticals Inc. is a Great Place to Work®

Tuesday, February 7, 2022 Seaford Pharmaceuticals Inc. is proud to announce that we have been certified as a Great Place to Work® after a thorough, independent analysis conducted by Great Place to Work Institute® Canada. This certification is based on employees’ direct feedback as part of an extensive and anonymous survey about their workplace experience. As … Continue reading “It’s Official, Seaford Pharmaceuticals Inc. is a Great Place to Work®”

Seaford’s 31st Anniversary

Internal Interview Thursday, November 24, 2022 Seaford Pharmaceuticals is a proudly Canadian company founded in 1991. Since then, we have been dedicated to developing and marketing specialty healthcare solutions to Canadians and abroad. Tamara Seales, president of Seaford Pharmaceuticals Inc., is proudly carrying on the legacy established by her father. We interviewed Tamara to learn … Continue reading “Seaford’s 31st Anniversary”